Navigation Links
Caprion Awarded US $12.9M Infectious Disease Biomarker Research Contract
Date:10/6/2008

MONTREAL, Oct. 6 /PRNewswire/ -- Caprion Proteomics Inc. announced today that it has been awarded a $12.9 million contract by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the US National Institutes of Health, to carry out Biodefense research in the area of infectious disease biomarkers.

Under the contract to be performed over a five-year period, Caprion will act as one of two NIAID Clinical Proteomics Centers for Infectious Disease & Biodefense, and will employ its distinctive CellCarta(R) quantitative protein profiling technologies to perform several large scale applied proteomics projects using human clinical samples from patients with infectious diseases. The projects will be aimed at the discovery, qualification, and verification of candidate biomarkers with potential for clinical use to improve detection and diagnosis and to monitor therapeutic and vaccine responses and susceptibility to infection for diseases caused by various pathogens. This second major Biodefense research contract awarded to Caprion by NIAID builds on the expertise and results demonstrated by Caprion as part of an initial contract awarded in 2004 and still in progress.

"We are very pleased to be granted the opportunity to expand our infectious disease research program with NIAID into the area of clinical biomarker discovery and validation," said Martin LeBlanc, President and CEO at Caprion. "This second major contract award from the NIAID provides further evidence of Caprion's solid scientific capabilities and industry leadership position as a proteomics and biomarker services provider."

Caprion will retain rights to commercialize candidate biomarkers and diagnostic products discovered in this project.

About Caprion Proteomics, Inc.

Caprion Proteomics is the leading provider of proteomics based services to the pharmaceutical industry. Caprion's proprietary proteomics discovery technology, CellCarta(R), is a gel-free,
'/>"/>

SOURCE Caprion Proteomics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. SpectraScience Awarded Patent for Its Optical Biopsy System and Methods for Tissue Diagnosis
2. Matthew B. Wiener, CEO of Pharmatech, Inc., Is Awarded the Cancer Leadership Award From the Colorado Cancer Coalition
3. GeneGo Is Awarded NCI Grant for Development of Systems Biology Database and Tools for Nutrition in Cancer in Collaboration with the FDA
4. PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program
5. Microchip Biotechnologies, Inc. Awarded Contract Under US Army Commercialization Pilot Program
6. eGenomics Awarded First U.S. Patent Covering Rapid DNA Sequencing Technology Platform to Control Hospital-Acquired Infections
7. Dr. Yong Shi awarded NSF grant
8. Advanced Life Sciences Awarded U.S. Department of Defense Biodefense Contract Valued at up to $3.8 Million
9. BioNanomatrix Awarded New NIH Grant for Development of Nanoscale Platform for Single-Molecule DNA Mapping and Haplotype Applications
10. U.S. Genomics Awarded $9.1 Million Contract for Development of Advanced Biosensor by the U.S. Department of Homeland Security
11. ImQuest Awarded SBIR Grant to Define the Mechanism of Action of Their Lead Anti-HIV Therapeutic Compound IQP-0410
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... -- Research and Markets  has announced the ... Polymer, Food & Beverage, Personal Care & Pharmaceutical) ... report to their offering. Lactic acid ... carbon atom. The main applications of lactic acid ... personal care product, and pharmaceutical industries. Lactic ...
(Date:8/27/2014)... “We are honored to be named to this ... of Radiant Sage. “We are offering truly ground-breaking clinical ... market to a different level. We are enabling ... and effectively manage the massive amounts of medical imaging ... read by trained physicians. Being recognized by technology industry ...
(Date:8/27/2014)... Flagship Biosciences LLC, a leading provider ... pharmaceutical and medical device industries, has announced a laboratory ... company has consolidated its histology and tissue analysis operations ... CO, just north of Denver. The new addresses ... Ave., Suite 100, Westminster, CO 80021 , Tissue Image ...
(Date:8/27/2014)... -- ARCH Venture Partners, one of the largest U.S. ... seed and early-stage advanced technology companies, today announced ... than $400 million in subscriptions. ARCH Venture Fund ... more than $150 million. "The enthusiasm ... of our approach to finding and funding new ...
Breaking Biology Technology:Global Lactic Acid (Biodegradable Polymer, Food & Beverage, Personal Care & Pharmaceutical) Market - Trends & Forecasts to 2019 2Radiant Sage Named to CIOReview List of 100 Most Promising Technology Companies 2Flagship Biosciences Announces Relocation and Expansion 2Latest ARCH Venture Partners Fund Closes Above $400 Million 2Latest ARCH Venture Partners Fund Closes Above $400 Million 3
... "We Want to Double our Sales Within Three Years", ... in,sales of EUR 3.4 million to EUR 17 million, ... the path of significant growth in 2007. "We want ... years," states CEO Nikolaus Uleer.,With the construction of the ...
... 10 Arena Pharmaceuticals,Inc. (Nasdaq: ARNA ) today ... 2007 after the NASDAQ Global Market closes on Wednesday,October ... and,Chief Executive Officer, and Robert E. Hoffman, Arena,s Vice ... call at 5:00,p.m. Eastern Time (2:00 p.m. Pacific Time) ...
... (ED) hold a,critical key in improving acute coronary ... all the tools that you need to improve ... to Better Myocardial,Infarction Outcomes: Emergency Departments Hold the ... experts, Deborah Diercks, MD; James Hoekstra, MD; and,Charles ...
Cached Biology Technology:Dr. Suwelack Skin & Health Care: New Product in the FDA Certification Process 2Arena Pharmaceuticals to Report Third Quarter 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, October 17, 2007 2Arena Pharmaceuticals to Report Third Quarter 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, October 17, 2007 3UPDATE: Free CME-certified Webcast: Opening the Door to Better Myocardial Infarction Outcomes: Emergency Departments Hold the Key 2UPDATE: Free CME-certified Webcast: Opening the Door to Better Myocardial Infarction Outcomes: Emergency Departments Hold the Key 3
(Date:8/27/2014)... that exists as five strains, none of which have ... the Sudan ebolavirus (SUDV). Although not the strain currently ... as recently as 2012. In a new study appearing ... now report a possible therapy that could someday help ... Sidhu, Jonathan Lai and colleagues explain that about 50-90 ...
(Date:8/27/2014)... or abandoned each year in U.S. waters and become ... catch fish, crabs, and other species such as turtles. ... the watermen who depend on the resources--losses that are ... , The report, published in the Marine Pollution ... examine the derelict fish trap problem, and so-called "ghost ...
(Date:8/27/2014)... has shown that piglets can be weaned later with ... outcome of the study at the University,s Roseworthy campus, ... is an important finding for pig producers. It allows ... production. , "Sows don,t usually start their oestrous cycles ... piglets have been weaned," says Ms Alice Weaver, PhD ...
Breaking Biology News(10 mins):Potential therapy for the Sudan strain of Ebola could help contain some future outbreaks 2NOAA's Marine Debris Program reports on the national issue of derelict fishing traps 2Piglet weaning age no bar to litter frequency 2
... The New York Stem Cell Foundation (NYSCF) Research Institute in ... Mount Sinai (ISMMS) successfully generated a stem cell model of ... identified fourteen genes that may be implicated in the disease ... inflammation may play in the brain of Alzheimer,s patients. ...
... 2014)- The leatherback turtle in the Pacific Ocean is one ... has declined by more than 90 percent since 1980. One ... set thousands of hooks in the ocean to catch fish, ... technology, researchers are now able to predict where fisheries and ...
... with a heart defect such as a hole in the heart, ... quickly and safely secure devices inside the heart. Sutures take too ... tissue, and currently available clinical adhesives are either too toxic or ... or under dynamic conditions, such as in a beating heart. ...
Cached Biology News:Stem cell research identifies new gene targets in patients with Alzheimer's disease 2Stem cell research identifies new gene targets in patients with Alzheimer's disease 3GPS traffic maps for leatherback turtles show hotspots to prevent accidental fishing deaths 2GPS traffic maps for leatherback turtles show hotspots to prevent accidental fishing deaths 3Bio-inspired glue keeps hearts securely sealed 2Bio-inspired glue keeps hearts securely sealed 3
assays for phosphatase, lipase, nucleoside triphosphatases (ATPase, GTPase etc). HTS and follow up studies for phosphatase inhibitors. Quantitation of phosphate content in protein, lipids, and DNA....
EnzChek cellulase substrate *blue fluorescent, 339/452...
... Kb RNA Ladder is suitable for sizing single-stranded RNA ... or formaldehyde agarose gels. The ladder consists of nine ... 4 6 8 and 10 kb) to simplify size ... the other bands allowing easy orientation and identification of ...
...
Biology Products: